FDA NDC Directory · JSON-LD · Markdown

Rufinamide

NDC 31722-688 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA216841
Dosage form / routeSUSPENSION · ORAL
Active ingredientsRUFINAMIDE (40 mg/mL)
Marketing started20231205
Package count1

External sources

Source: openFDA. Public-domain (CC0).